May 10, 2019
Q1 2019 General Market Overview
Media
May 09, 2019
Pulmonx Closes $65 Million Financing and Adds Chief Financial Officer
May 09, 2019
Targovax ASA: First quarter 2019 results
May 09, 2019
Strongbridge Biopharma plc Presents KEVEYIS® (dichlorphenamide) Primary Periodic Paralysis (PPP) Data at the 2019 American Academy of Neurology Annual Meeting
May 08, 2019
Altimmune to Announce First Quarter 2019 Financial Results on May 15
May 08, 2019
NEW CEO OF MIPS
May 08, 2019
Targovax announces completed enrollment of ONCOS-102 trial in mesothelioma
May 07, 2019
GenSight Biologics announces positive Data Safety Monitoring Board review and continuation of PIONEER Phase I/II clinical trial of GS030 combining gene therapy and Optogenetics for the treatment of Retinitis Pigmentosa
May 06, 2019
GenSight Biologics announces presentation of 72-week data from the REVERSE Phase III trial of GS010 at the Annual Meeting of the American Academy of Neurology (AAN)
May 03, 2019
MIPS – WORLD’S FIRST HOCKEY HELMET WITH MIPS BRAIN PROTECTION SYSTEM ANNOUNCED
